Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
17.17
-1.15 (-6.28%)
Jun 10, 2026, 2:48 PM EDT - Market open

Omada Health Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Omada Health stock has a consensus rating of "Buy" and an average price target of $22.92. The average 1-year stock price forecast is 33.49% higher than the current stock price, while the lowest is $15 (-12.64%) and the highest is $30 (+74.72%).

Price Target: $22.92 (+33.49%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$15$22.92$22.5$30
Change-12.64%+33.49%+31.04%+74.72%

Analyst Ratings

The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy555555
Buy444455
Hold122222
Sell000000
Strong Sell000000
Total101111111212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$30
BuyReiterates$30+74.72%May 19, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$15$20
BuyMaintains$15$20+16.48%May 8, 2026
BMO Capital
BMO Capital
Buy
Maintains
$18$20
BuyMaintains$18$20+16.48%May 8, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$22$24
BuyMaintains$22$24+39.78%May 8, 2026
Goldman Sachs
Goldman Sachs
Buy
Maintains
$23$26
BuyMaintains$23$26+51.43%May 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
327.31M
from 260.21M
Increased by 25.79%
Revenue Next Year
392.53M
from 327.31M
Increased by 19.93%
EPS This Year
0.33
from 0.15
Increased by 110.87%
EPS Next Year
0.48
from 0.33
Increased by 45.89%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
89.19M122.78M169.80M260.21M327.31M
Revenue Growth
-37.67%38.29%53.25%25.79%
Gross Profit
42.79M69.97M102.88M170.94M223.51M
Gross Margin
47.98%56.99%60.59%65.69%68.29%
Operating Income
-72.35M-66.00M-43.65M-11.97M-4.20M
Net Income
-72.52M-67.51M-47.14M-12.78M-1.18M
EPS
---0.150.33
EPS Growth
----110.87%
Forward PE
----52.57
Free Cash Flow
--29.39M-14.46M15.34M21.70M
No. Analysts
----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High330.5M
Avg327.3M
Low325.0M

Revenue Growth

Revenue Growth202620272028
High
27.0%
Avg
25.8%
Low
24.9%

EPS Forecast

EPS202620272028
High-
Avg0.33
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
110.9%
Low-